Moderna Unusual Options Activity
Moderna Unusual Options Activity
Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 19 unusual trades.
金融巨头对Moderna采取了明显的看淡态度。我们对Moderna(纳斯达克:MRNA)的期权历史进行了分析,发现了19笔异常交易。
Delving into the details, we found 42% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 12 were puts, with a value of $856,535, and 7 were calls, valued at $481,149.
深入了解细节后,我们发现42%的交易者看好,而47%的交易者表现出看淡趋势。在我们发现的所有交易中,有12笔看跌期权,价值856,535美元,有7笔看涨期权,价值481,149美元。
What's The Price Target?
目标价是多少?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $150.0 for Moderna, spanning the last three months.
在评估交易量和持仓量后,很明显市场的主要动向是在60.0美元和150.0美元之间的价格区间内,这一情况持续了三个月。对于Moderna来说,这个价格区间成为主要的市场动向。
Analyzing Volume & Open Interest
分析成交量和未平仓合约
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $60.0 to $150.0 in the last 30 days.
在交易期权时,关注成交量和持仓量是一个强有力的策略。这些数据可以帮助您跟踪给定行权价的Modern的期权的流动性和兴趣。下面,我们可以观察过去30天内所有现货交易中,行权价范围从60.0美元到150.0美元的看涨和看跌期权的成交量和持仓量的变化。
Moderna 30-Day Option Volume & Interest Snapshot
Moderna 30天期权成交量和利息快照
Largest Options Trades Observed:
观察到的最大期权交易:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
MRNA | PUT | SWEEP | BEARISH | 06/20/25 | $6.05 | $5.95 | $6.02 | $60.00 | $362.0K | 668 | 600 |
MRNA | CALL | TRADE | BEARISH | 09/06/24 | $1.28 | $1.2 | $1.21 | $83.00 | $180.8K | 151 | 1.5K |
MRNA | CALL | TRADE | BEARISH | 09/06/24 | $1.15 | $0.93 | $1.01 | $84.00 | $136.3K | 167 | 27 |
MRNA | PUT | SWEEP | BULLISH | 01/17/25 | $14.1 | $13.95 | $13.95 | $85.00 | $100.4K | 3.3K | 72 |
MRNA | PUT | SWEEP | BULLISH | 09/13/24 | $2.39 | $2.15 | $2.21 | $77.00 | $70.0K | 69 | 317 |
标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
---|---|---|---|---|---|---|---|---|---|---|---|
Moderna | 看跌 | SWEEP | 看淡 | 06/20/25 | $6.05 | $5.95 | $6.02 | $60.00 | RSI indicators hint that the underlying stock may be oversold. | 668 | 600 |
Moderna | 看涨 | 交易 | 看淡 | 09/06/24 | $1.28 | $1.2 | $1.21 | 83美元 | 151 | 1.5K | |
Moderna | 看涨 | 交易 | 看淡 | 09/06/24 | $1.15 | $0.93 | $1.01 | 84美元 | $136.3K | 167 | 27 |
Moderna | 看跌 | SWEEP | 看好 | 01/17/25 | $14.1 | $13.95 | $13.95 | $85.00 | $100.4K | 3.3K | 72 |
Moderna | 看跌 | SWEEP | 看好 | 09/13/24 | $2.39 | $2.15 | $2.21 | $77.00 | $70.0K | 69 | 317 |
About Moderna
关于现代
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Moderna是一家成立于2010年并于2018年12月进行首次公开发行的商业化生物技术公司。该公司的mRNA技术得到了验证,其COVID-19疫苗在2020年12月获得美国授权。截至2023年中期,Moderna共有39个mRNA开发候选药物处于临床试验中。这些项目涉及多个治疗领域,包括传染病、肿瘤、心血管疾病和罕见遗传疾病。
In light of the recent options history for Moderna, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鉴于Moderna的最近期权历史,现在应该关注该公司本身。我们打算探讨其当前表现。
Current Position of Moderna
Moderna现有状态
- With a volume of 2,549,863, the price of MRNA is down -3.43% at $78.86.
- RSI indicators hint that the underlying stock may be oversold.
- Next earnings are expected to be released in 65 days.
- RSI指标表明该基础股票可能被超卖。
- 下一季度财报将在65天内发布。
Professional Analyst Ratings for Moderna
Moderna的专业分析师评级
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $127.2.
- Reflecting concerns, an analyst from RBC Capital lowers its rating to Sector Perform with a new price target of $90.
- Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for Moderna, targeting a price of $178.
- An analyst from RBC Capital persists with their Outperform rating on Moderna, maintaining a target price of $125.
- Maintaining their stance, an analyst from JP Morgan continues to hold a Neutral rating for Moderna, targeting a price of $88.
- An analyst from Barclays has decided to maintain their Overweight rating on Moderna, which currently sits at a price target of $155.
- RBC Capital的分析师仍然坚持对Moderna的跑赢大盘评级,目标价为125美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Moderna with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险,但也提供更高的利润潜力。精明的交易者通过持续教育、战略性交易调整、利用各种因子、并密切关注市场动态来减轻这些风险。使用Benzinga Pro实时警报, 追踪Moderna的最新期权交易。